Reminiscence Therapy on Depression, Self Esteem, Life Satisfaction, and Loneliness of the Elderly

Depression Clinical Trial

Official title:

The Effects of Reminiscence Therapy on Depression, Self Esteem, Life Satisfaction, and Loneliness of the Elderly in China

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01553669
• Other study ID #: 2009BAI77B03
• Status: Recruiting
• Phase: Phase 2
• First received: March 6, 2012
• Last updated: May 14, 2012
• Start date: October 2011
• Est. completion date: September 2012

Study information

• Verified date: May 2012
• Source: Chinese Academy of Sciences
• Contact: Tingji Chen, master
• Phone: (086)18610249921
• Email: Chentj[@]psych.ac.cn
• Is FDA regulated: No
• Health authority: China: Ministry of Science and Technology
• Study type: Interventional

Clinical Trial Summary

The primary hypothesis is, comparing with the control group, reminiscence therapy is significantly and clinically effective to improve the experiment group's depressive symptoms after six weeks therapy, and the efficacy can be maintained on the three months follow-up.

The secondary hypothesis is, comparing with the control group, reminiscence therapy significantly reduce the loneliness and increase the self-esteem and life satisfaction of the experiment group.

Description:

The subjects who are arranged to the experiment group will be intervened using the reminiscence therapy manual proposed by Watt and Cappeliez (2000). According to the manual, the group consisted of six weekly sessions of 90 min each. During each weekly session, the memories recalled focused on a different theme.

Data collection will occur on screening (as for baseline or pre-test), after intervention immediately (as for post-test), and three months after the intervention (as for follow-up). And outcome measures use standardized instruments with demonstrated validity and reliability:

Geriatric Depression Scale (GDS) Rosenberg self-esteem scale (SES) Life Satisfaction Index A (LSI-A) Russell's UCLA Loneliness Scale

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: September 2012
• Est. primary completion date: September 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

1. 60 years of age and older;

2. A score above 10 and lower than 26 on the Geriatric Depression Scale (GDS);

3. A score of 24 or higher on the Mini-Mental State Examination (MMSE);

4. Not taking anti-depressant medication or taking part in other psychotherapy when enrolling, if taking anti-depressant medication, must be stabilized on that medication for at least three months;

5. Having no problem with communication (such as, can speak fluent mandarin, or if he/she speaks a dialect, his/her dialect can be understood by most of people).

Exclusion Criteria:

1. Suicide attempt;

2. A diagnosis of cognitive impairment by DSM-?, or mental disorders other than depression;

3. Alcohol or drug abuse;

4. Cannot grantee attending the therapy at a weekly base due to physical impairment, lack of time or unwilling etc.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Behavioral:
• reminiscence therapy
The subjects who are arranged to the experiment group will be intervened using the reminiscence therapy manual proposed by Watt and Cappeliez (2000). According to the manual, the group consisted of six weekly sessions of 90 min each. There will be about four people in each subgroup. During each weekly session, the memories recalled focused on a different theme.

Locations

Country	Name	City	State
China	Chinese Academy of Sciences, Institute of Psychology, Center on Ageing Psychology, Key Lab of Mental Health	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Chinese Academy of Sciences

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in depression using the Geriatric Depression Scale(GDS)		the 6th and 18th week	Yes
Secondary	Change in self esteem using the Self-Esteem Scale (SES)		the 6th and 18th week	Yes
Secondary	Change in life satisfaction using the Life Satisfaction Index A (LSI-A)		the 6th and 18th week	Yes
Secondary	Change in loneliness using Russell's UCLA Loneliness Scale		the 6th and 18th week	Yes